Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 546

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 546
---
 the EAR.

(k) “Business” means the research, development, use, making, manufacture, marketing, promotion, commercialization, sale,
distribution, grant to license, or import or export (as applicable) of (i) the Specified Company Products and (ii) any products currently under investigation by the Company as conducted by Seller and the Company as of or prior to the
Closing, excluding any products related to any transactions included in .

(l) “Business Day” means
each day that is not a Saturday, Sunday or other day on which the Federal Reserve Bank of San Francisco is closed or commercial banks in Tokyo, Japan are closed.

(m) “Bylaws” means the bylaws of the Company in effect as of the date of this Agreement.

(n) “Capitalization Date” means 5:00 p.m. Pacific time as of December 16, 2024.

(o) “Charter” means the Amended and Restated Certificate of Incorporation of the Company, as amended, and in effect as of the
date of this Agreement.

(p) “Chosen Courts” means the Court of Chancery of the State of Delaware and any state appellate
court therefrom within the State of Delaware (or, if the Court of Chancery of the State of Delaware does not have subject matter jurisdiction, the United States District Court for the District of Delaware, or, if jurisdiction is not then available
in the United States District Court for the District of Delaware, then any Delaware state court).

(q) “Clinical Trial”shall mean any study in which human subjects are dosed or treated with a pharmaceutical or biological product, whether approved or investigational.

(r) “Closing Adjustment Amount” means the Closing Company Cash Amount, less the Closing Company Indebtedness Amount,
lessthe Closing Company Transaction Expense Amount, lessthe Closing Negative Net Working Capital Adjustment, plusthe Closing Positive Net Working Capital Adjustment.

A-3

(s) “Closing Company Cash Amount” means an amount equal to the difference
of (a) the aggregate amount of all cash and cash equivalents (other than Restricted Cash) of the Company as of the Measurement Time,minus (b) the amount of any overdrafts and any amounts required to cover checks, wires and similar
instruments issued by the Company which have not cleared as of the Measurement Time.

(t) “Closing Company Indebtedness Amount” means all Indebtedness of the Company determined and valued as of the Measurement Time in accordance with